Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration Two-Year Results

Overview of attention for article published in Ophthalmology, May 2012

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 6 news outlets
blogs: 1 blog
policy: 5 policy sources
twitter: 12 X users
patent: 35 patents

facebook: 1 Facebook page
wikipedia: 3 Wikipedia pages
reddit: 1 Redditor
f1000: 1 research highlight platform
guideline: 6 clinical guideline sources

Readers on

mendeley: 642 Mendeley

So far, Altmetric has seen 3 citations on 3 Wikipedia pages.

Serbian

Anti-VEGF terapija u oftalmologiji

Cited by user KrleNS on 15 Sep 2023

Anti-VEGF terapija u oftalmologiji je primena lekova sa anti-vaskularnim endotelijalnmi faktorom rasta u lečenju bolesti oka sa ciljem da se spreči stvaranje novih…

English

National Eye Institute

Cited by user Jmertel23 on 13 Jun 2019

The National Eye Institute (NEI) is part of the U.S. National Institutes of Health (NIH), an agency of the U.S.

Arabic

بيفاسيزوماب

Cited by user Mahmoudalrawi on 07 Mar 2013

This page shows the most recent Wikipedia articles that mention this research output. Click here to find out how to access more activity.